Favorable COVID-19 course despite significant comorbidities in a ruxolitinib-treated patient with primary myelofibrosis

Viral Infections, Non-HIV

Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study

QJM.

Rojas-Marte GR, Khalid M, Mukhtar O, Hashmi AT, Waheed MA, Ehrlich S, Aslam A, Siddiqui S, Agarwal C, Malyshev Y, Henriquez-Felipe C, Sharma D, Sharma S, Chukwuka N, Rodriguez DC, Alliu S, Le J, Shani J

doi: 10.1093/qjmed/hcaa206.

Viral Infections, Non-HIV

Early Short Course Corticosteroids in Hospitalized Patients with COVID-19

Clin Infect Dis.

Fadel R, Morrison AR, Vahia A, Smith ZR, Chaudhry Z, Bhargava P, Miller J, Kenney RM, Alangaden G, Ramesh MS, Henry Ford COVID-19 Management Task Force.

doi: 10.1093/cid/ciaa601.

Viral Infections, Non-HIV

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study

Clin Microbiol Infect.

Nachtigall I, Lenga P, Jóźwiak K, Thürmann P, Meier-Hellmann A, Kuhlen R, Brederlau J, Bauer T, Tebbenjohanns J, Schwegmann K, Hauptmann M, Dengler J

doi: 10.1016/j.cmi.2020.08.011.

SPECIAL REPORT

HIV / AIDS

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021

Viral Infections, Non-HIV

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study

Int J Med Sci.

Pan F, Yang L, Li Y, Liang B, Li L, Ye T, Li L, Liu D, Gui S, Hu Y, Zheng C

doi: 10.7150/ijms.46614.

Viral Infections, Non-HIV

Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin

Br J Clin Pharmacol.

Kelly M, O'Connor R, Townsend L, Coghlan M, Relihan E, Moriarty M, Carr B, Melanophy G, Doyle C, Bannan C, O'Riordan R, Merry C, Clarke S, Bergin C

doi: 10.1111/bcp.14482.

Viral Infections, Non-HIV

Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease

Coron Artery Dis.

Barman HA, Atici A, Sahin I, Alici G, Aktas Tekin E, Baycan ÖF, Ozturk F, Oflar E, Tugrul S, Yavuz MB, Celik FB, Oktay A, Vahaboglu H, Adas M, Turgut N, Okuyan E, Yıldırmak MT, Gungor B

doi: 10.1097/MCA.0000000000000914.

Viral Infections, Non-HIV

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Trials.

Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB

doi: 10.1186/s13063-020-04535-4.

Viral Infections, Non-HIV

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

JAMA.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, and the Northwell COVID-19 Research Consortium., Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP

doi: 10.1001/jama.2020.6775.

Related content

Outcomes in Patients with Severe COVID-19 Disease Treated with Tocilizumab - A Case- Controlled Study

Early Short Course Corticosteroids in Hospitalized Patients with COVID-19

Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study

11e Conférence de la Société internationale sur le SIDA (IAS) 2021

Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study

Clinical outcomes and adverse events in patients hospitalised with COVID -19, treated with off- label hydroxychloroquine and azithromycin

Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

11^e Conférence de la Société internationale sur le SIDA (IAS) 2021